CUMBERLAND PHARMACEUTICALS RECEIVES VIZIENT CONTRACT FOR NEW VIBATIV® 4-VIAL STARTER PAK

Vizient serves more than 65% of the nation's acute care providers, including 97% of academic medical centers

NASHVILLE, Tenn., Aug. 4, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on delivering high-quality products to improve patient care, announced the availability of the Vibativ^® (telavancin) 4-Vial Starter Pak through a new contract with Vizient^®, the nation's largest provider-driven healthcare performance improvement company.

Read more at prnewswire.com